News & Updates

Children with gestational exposure to systemic glucocorticoids face an increased risk of having kidney disease, according to a retrospective cohort study.

Once-daily application of tapinarof cream 1% significantly improves the Eczema Area Severity Index (EASI) score in patients with atopic dermatitis (AD), regardless of their disease severity or age, according to the pivotal phase III ADORING 1 and 2 trials presented at AAAAI 2024.

Ruxolitinib cream, a topically administered selective Janus kinase 1/2 inhibitor, appears to be effective for mild-to-moderate atopic dermatitis (AD) in children aged 2–11 years, according to the TRuE-AD3 trial presented at AAAAI 2024.

Pregnant moms who use tobacco, alcohol, marijuana, or cocaine may be putting their babies at risk of several types of cancer, including nonglioma central nervous system tumours and non-Hodgkin lymphoma, as shown in a study.

Babies born to mothers who were vaccinated against COVID-19 during pregnancy are not at risk of developmental delays, according to a study.

Physical activity appears to be beneficial in children and adolescents with different types of neurodevelopmental disorders, with such interventions having positive effects on cognitive function, psychological well-being, internalizing, and externalizing problems, according to the results of a systematic review and meta-analysis.

In the phase III KONFIDENT trial, oral sebetralstat provides rapid symptom relief, cuts treatment burden, and facilitates early treatment in individuals with hereditary angioedema (HAE) attacks.